In transcriptomics data from AML patients (Ley et al., 2013), we found mildly but significantly increased expression of Cxcr4 in the M5 (monocytic differentiation) subtype and in MLL-rearranged AML (Figures S2A and S2B). Here, KMT2A is linked to acute myeloid leukemia.